✦ LIBER ✦

Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene

✍ Scribed by Loredana Elia; Sara Grammatico; Francesca Paoloni; Marco Vignetti; Angela Rago; Natalia Cenfra; Sergio Mecarocci; Marco Mancini; Matteo Luciani; Francesco Di Raimondo; Giovanni Cazzaniga; Mabel Matarazzo; Maria Luisa Moleti; Lidia Santoro; Gianluca Gaidano; Robin Foà; Franco Mandelli; Giuseppe Cimino

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 431 KB
Volume: 86
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.22161

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Minimal residual disease (MRD) monitorin

Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients

✍ Tomomi Toubai; Junji Tanaka; Shuichi Ota; Takashi Fukuhara; Satoshi Hashino; Tak 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

The value of monitoring minimal residual

The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

✍ Xiao Ma; Depei Wu; Aining Sun; Huiying Qiu; Zhenzhen Fu; Xiaojin Wu; Suning Chen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 1 views